# STOCKHOLM 1.0
#=GF ID   EpoR_lig-bind
#=GF AC   PF09067.14
#=GF DE   Erythropoietin receptor, ligand binding
#=GF AU   Sammut SJ;0000-0003-4472-904X
#=GF SE   pdb_1eer
#=GF GA   27.30 27.30;
#=GF TC   27.30 27.30;
#=GF NC   27.20 27.20;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -Z 75585367 --cpu 4 -E 1000 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0159
#=GF RN   [1]
#=GF RM   9774108
#=GF RT   Efficiency of signalling through cytokine receptors depends
#=GF RT   critically on receptor orientation. 
#=GF RA   Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H,
#=GF RA   Osslund TD, Chirino AJ, Zhang J, Finer-Moore J, Elliott S,
#=GF RA   Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J, Stroud
#=GF RA   RM; 
#=GF RL   Nature. 1998;395:511-516.
#=GF DR   INTERPRO; IPR015152;
#=GF DR   SCOP; 1eer; fa;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   Members of this family interact with erythropoietin (EPO), with
#=GF CC   subsequent initiation of the downstream chain of events
#=GF CC   associated with binding of EPO to the receptor, including
#=GF CC   EPO-induced erythroblast proliferation and differentiation
#=GF CC   through induction of the JAK2/STAT5 signaling cascade. The
#=GF CC   domain adopts a secondary structure composed of a short
#=GF CC   amino-terminal helix, followed by two beta-sandwich regions [1].
#=GF SQ   12
#=GS EPOR_HUMAN/37-140    AC P19235.1
#=GS Q6IYE8_CHICK/37-134  AC Q6IYE8.1
#=GS TPOR_HUMAN/25-128    AC P40238.1
#=GS Q6UAP8_TETNG/19-116  AC Q6UAP8.1
#=GS Q9PTH9_XENLA/24-123  AC Q9PTH9.1
#=GS Q9DE08_ONCMY/21-118  AC Q9DE08.1
#=GS Q8QG54_CYPCA/18-116  AC Q8QG54.1
#=GS Q6UAP7_TETNG/33-133  AC Q6UAP7.1
#=GS Q2VBQ8_DANRE/29-130  AC Q2VBQ8.1
#=GS EPOR_XENLA/43-139    AC Q4W815.1
#=GS Q6EIY6_DANRE/23-122  AC Q6EIY6.1
#=GS Q6UAN4_TETNG/34-131  AC Q6UAN4.1
EPOR_HUMAN/37-140               SKAA.LLAARGPEELLCFTERLEDLVCFWEEAASAGVGPGNYSFSYQLED.EPWKLCRLHQAPTARGAV.RFWCSLPTA.DTSSFVPLELRV.TAASGAPRYHRVIHIN
Q6IYE8_CHICK/37-134             SQDA.ALLAEVPEDILCFSRSFEDLTCFWDEEEASAI....HRFYYW....DAPTTCAVSTQRSGVSGM.RHICVFPSQ.DVRLFTPLHVLVLDTTTNRTRHRRELSVD
TPOR_HUMAN/25-128               SQDV.SLLASDSEPLKCFSRTFEDLTCFWDEEEAAPSGT..YQLLYAYPR.EKPRACPLSSQSMPHFGT.RYVCQFPDQEEVRLFFPLHLWVKNVFLNQTRTQRVLFVD
Q6UAP8_TETNG/19-116             SSEG.TSPPGKPTLIQCRSPEKETFTCWWKPGSDGDLPTT.YALYYRKENSDTVHECPDYQTAGENS......CFFNKN.NTSLWVYYNITVVATNELGSTFSD..SVD
Q9PTH9_XENLA/24-123             SLNA.QSPPGKPEIIKCRSYEKVTFSCWWKPASDGGLPTN.YSLLYRKENDPKIYECPDYETSGLNS......CYFDKA.HTSFWVFYHIYVNATNALGSNVSEELSVD
Q9DE08_ONCMY/21-118             QGAR.HTPPGKPKLTSCRSPDKETFTCWWEAGSDGGRPTT.YSLFYHKENSETVYECPDYHTAGANS......CFFNKN.ETSIWVNYNITVVATNALGNNFSD..PVD
Q8QG54_CYPCA/18-116             SQAAGVSAPGKPKLTSCRSPEKETFTCWWEPGEDGGLPTT.YALYYHLENSETVYECPDYKTAGNNS......CFFNKN.DTSLWVNYNITVVATNALGKNISE..PVE
Q6UAP7_TETNG/33-133             KKVS.IMLKEDPKNPKCFAEGRKDFICFWEEDEERAGSVDQYTFTYAYQN.ENSSRCPLKSISAADSKR.LFICHLN...RIKMFVQMDIQV..HREGMLIHNRSLLVE
Q2VBQ8_DANRE/29-130             SKVA.QLIRDETEDIKCFVEGKKDFTCFWEKEDGTNYSQDNYTFTYTYMN.ENKMDCAVSSLFLLSSNRSVFFCKLP...KALFFTSLDVQV..LRDGQMLYNRSLNVE
EPOR_XENLA/43-139               RHIS.EKIPEEYQNPHCFTRDLNDFICFWEGERRKN.....ASFSYSED..DQIKWCQLRTEVASNNTW.WYICEFPVT.DVVLFAGITISA..YPCHKCQTAREIYIN
Q6EIY6_DANRE/23-122             RQPK.PELLAMDEDPKCFTRNLEDFTCFWDAPVEKS.....YDFLYIIEGLMEEKRCDVKQQTFEEKI..LNICTFPPS.DVYLYVETHIRVIDKDTNTTIYSRAVSVE
Q6UAN4_TETNG/34-131             SEED.LLLFKDDEFLKCFTSTQFDFTCFFETSDNRT.....YDLSYNVNG...TEMCELFVRKTDEGTL.LHICSFPEV.DVHLFVEIHLEVGERGTNTSLYNRTVCVE
#=GC seq_cons                   Spsu..hhstcsc.hpCFopshcDFTCFW-tspssshs...YshhYphps.-phppCslhppssssu...h.hChFsps.-splaV.hclpV.spssttspasR.lsV-
